Posts by Andrew Mahoney

4 Top Takeaways from ASGCT’s 26th Annual Meeting

Last week, Bobby Moy, managing director of Clarion, a Lumanity business, attended the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) in Los Angeles, California. Here, he shares four key takeaways from the conference: Are you a company that is looking for guidance in the rare disorder and/or gene therapy…

Read More

Bridging the Gap in Translation and Innovation: Oncology’s PoS Problem

By: Dennis Chang Oncology drug development has produced remarkable breakthroughs in the last decade, including various immunotherapies and precision medicine approaches, offering hope for previously incurable cancers. However, the probability of success (PoS) in oncology is among the lowest of all therapeutic areas: the likelihood of regulatory approval for programs entering Phase 1 is only…

Read More

Is Clarion the right place to advance your career?

Find out more about joining Clarion’s team of innovation advisors.

A life sciences strategy and organizational consultancy that collaborates with its clients to envision, craft and enable growth through innovation and leadership.